ICN Reports Record Quarterly Income
- Share via
ICN Pharmaceuticals Inc., the Costa Mesa manufacturer of prescription and over-the-counter drugs, said that net income for the first quarter rose to a record $22 million, or 65 cents a share, up 29% from $17 million, or 57 cents a share, a year ago. Sales rose 5% to $138.2 million from $132.2 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
